Code | 6872E | ||||||||||
MA number | 59/0181/24-S | ||||||||||
Product Form: | cps dur 14x0,5 mg (blis. PVC/PE/PVDC/Al) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Pharmaselect International Beteiligungs GmbH, Austria | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | blister PVC/PE/PVDC/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 14.08.2024 |
Validity: | 14.08.2029 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
PIL: | PIL_Fingolimod Pharmaselect 0,5 mg tvrdé kapsuly_07 2024.pdf |
SPC: | SPC_Fingolimod Pharmaselect 0,5 mg tvrdé kapsuly_07 2024.pdf |
Safety feature | Yes |
Data update: | 23.08.2024 |